For recovery-focused patients, our Wolverine protocol (BPC-157 + TB-500) addresses tissue repair through complementary mechanisms
The next-generation therapy combines semaglutide with cagrilintide, a long-acting analog of amylin, which is a pancreatic peptide that lowers blood glucose levels and slows down gastric emptying
The primary mechanisms include: Enhanced insulin secretion in response to elevated blood glucose levels, helping to lower blood sugar in people with type 2 diabetes Suppression of glucagon release from the pancreas, reducing glucose production by the liver Delayed gastric emptying , which slows the movement of food from the stomach into the small intestine Increased satiety through actions on appetite centres in the brain, leading to reduced food intake The slowing of gastric emptying is particularly significant when considering electrolyte balance
At NEUAGE, we offer personalized protocols tailored to your goals, high quality peptides from reputable pharmacies, comprehensive lab testing and monitoring, expert guidance from board certified specialists, and at home administration training